Mitra, D., Horick, N. K., Brackett, D. G., Mouw, K. W., Hornick, J. L., Ferrone, S., . . . Wo, J. Y. (2019). High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy. Oncologist.
Chicago Style CitationMitra, Devarati, et al. "High IDO1 Expression Is Associated With Poor Outcome in Patients With Anal Cancer Treated With Definitive Chemoradiotherapy." Oncologist 2019.
Cita MLAMitra, Devarati, et al. "High IDO1 Expression Is Associated With Poor Outcome in Patients With Anal Cancer Treated With Definitive Chemoradiotherapy." Oncologist 2019.
Atenció: Aquestes cites poden no estar 100% correctes.